Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is known that infection with …

Abstract Background Multiple Sclerosis (MS) is a chronic autoimmune disease, affecting
over 2.5 million people worldwide. There has been growing concern about the impact of …

Background Sequelae of COVID-19 in people with multiple sclerosis (PwMS) have not been
characterised. We explored whether COVID-19 is associated with an increased risk of …

Background Although certain subsets patients with multiple sclerosis (MS), an immune-
mediated disorder, are at higher risk of worse acute COVID-19 outcomes compared to the …

Background Upper respiratory viral infections have long been considered triggers for
multiple sclerosis (MS) relapse and exacerbation. The possible effects of SARS-CoV-2 …

Introduction An association between intercurrent viral respiratory infections and
exacerbations of Multiple Sclerosis (MS) disease activity has been proposed by several …

Background There is insufficient data on severe acute respiratory syndrome coronavirus
type-2 (SARS-CoV-2) infection in Chinese patients with multiple sclerosis (pwMS). This …

Objectives. Although patients with pre-existing Parkinson's disease (PD) are at a higher risk
of severe acute COVID-19 outcomes compared to matched controls, the long-term outcomes …

Objectives. This study investigated post COVID-19 outcomes of patients with pre-existing
neurological conditions up to 3.5 years post-infection. Methods. This retrospective study …

Мета—провести аналіз клінічної картини та перебігу розсіяного склерозу (РС) на тлі
коронавірусної хвороби-2019 (COVID-19) із застосуванням нейрофункціональних шкал …